Ultralife Corporation
ULBI | NASDAQ
$5.66
+$0.02 (+0.35%)
Sep 22, 2026, 11:53 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 191.16M | 164.46M | 158.64M | 131.84M | 98.27M | 107.71M |
Cost of Revenue | 146.66M | 122.14M | 119.44M | 102.44M | 73.63M | 78.55M |
Gross Profit | 44.5M | 42.31M | 39.2M | 29.4M | 24.64M | 29.16M |
Operating Income | 9.22M | 9.97M | 9.48M | 129K | 35K | 5.7M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -8.4M | 8.3M | 9.12M | -446K | -151K | 7.02M |
Net Income | -5.9M | 6.31M | 7.2M | -119K | -234K | 5.23M |
Selling & General & Admin | 26.28M | 24.08M | 22.19M | 22.19M | 17.78M | 17.51M |
Research & Development | 9M | 8.27M | 7.53M | 7.08M | 6.83M | 5.95M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 35.28M | 32.35M | 29.73M | 29.27M | 24.61M | 23.46M |
Interest Expense | 3.95M | 1.94M | 2.02M | 951K | 242K | 436K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 181.94M | 154.49M | 149.17M | 131.71M | 98.23M | 102.01M |
Income Tax Expense | -2.45M | 1.89M | 1.95M | -326K | 79K | 1.69M |
Shares Outstanding (Basic) | 16.64M | 16.56M | 16.36M | 16.13M | 16.04M | 15.9M |
Shares Outstanding (Diluted) | 16.64M | 16.77M | 16.23M | 16.13M | 16.04M | 16.1M |
EPS (Basic) | -0.35 | 0.38 | 0.44 | -0.01 | -0.01 | 0.33 |
EPS (Diluted) | -0.35 | 0.38 | 0.44 | -0.01 | -0.01 | 0.33 |
EBITDA | 1.05M | 14.4M | 15.04M | 4.96M | 3.63M | 10.39M |
EBIT | -4.45M | 10.24M | 11.13M | 505K | 91K | 7.46M |
Depreciation & Amortization | 5.5M | 4.16M | 3.91M | 4.46M | 3.54M | 2.94M |
Add to Watchlist
Select watchlists to add or remove ULBI